Beyond the Tip of the Iceberg: A Narrative Review to Identify Research Gaps on Comorbid Psychiatric Disorders in Adolescents with Methamphetamine use Disorder or Chronic Methamphetamine Use

Buck JM , Siegel JA. The effects of adolescent methamphetamine exposure. Front Neurosci. 2015;9(151):151.

Marshall BD , Werb D. Health outcomes associated with methamphetamine use among young people: a systematic review. Addiction. 2010;105(6):991–1002.

UNODOC. World Drug Report 2019 (United Nations publication, Sales No. E.19.XI.9). Vienna, Austria: United Nations Office on Drugs and Crime; 2019.

Yen CF , Yang YH , Chong MY. Correlates of methamphetamine use for Taiwanese adolescents. Psychiatry Clin Neurosci. 2006;60(2):160–167.

Zhuang SM , Chen F. Chinese adolescents and youth with methamphetamine dependence: prevalence and concurrent psychological problems. Nurs Res. 2016;65(2):117–124.

Sutcliffe CG , German D , Sirirojn B , . Patterns of methamphetamine use and symptoms of depression among young adults in northern Thailand. Drug Alcohol Depend. 2009;101(3):146–151.

Matsumoto T , Ozaki S , Kobayashi O , Wada K. Current situation and clinical characteristics of sedative-related disorder patients in Japan: comparison with methamphetamine-related disorder patients. Act Nerv Super. 2015;57(1):12–28.

Degenhardt L , Coffey C , Moran P , Carlin JB , Patton GC. The predictors and consequences of adolescent amphetamine use: findings from the Victoria Adolescent Health Cohort Study. Addiction. 2007;102(7):1076–1084.

McKetin R , McLaren J , Kelly E. The Sydney methamphetamine market: patterns of supply, use, personal harms and social consequences. In: National Drug Law Enforcement Research Fund Monograph, ed. Monograph Series, no. 13. Adelaide: Australian Centre for Policing Studies; 2005.

Ling W , Rawson R , Shoptaw S , Ling W. Management of methamphetamine abuse and dependence. Curr Psychiatry Rep. 2006;8(5):345–354.

Herbeck DM , Brecht ML , Lovinger K. Mortality, causes of death, and health status among methamphetamine users. J Addict Dis. 2015;34(1):88–100.

Chen LY , Strain EC , Alexandre PK , Alexander GC , Mojtabai R , Martins SS. Correlates of nonmedical use of stimulants and methamphetamine use in a national sample. Addict Behav. 2014;39(5):829–836.

Berg MK , Hobkirk AL , Joska JA , Meade CS. The role of substance use coping in the relation between childhood sexual abuse and depression among methamphetamine users in South Africa. Psychol Trauma. 2017;9(4):493–499.

Arnaud N , Thomasius R. Methamphetamine: epidemiology, clinical importance and sequelae of abuse. Nervenarzt. 2017;88(9):1079–1090.

Milin S , Lotzin A , Degkwitz P , Verthein U , Schäfer I. Amphetamin und Methamphetamin - Personengruppen mit missbräuchlichem Konsum und Ansatzpunkte für präventive Maßnahmen. Hamburg: Zentrum für Interdisziplinäre Suchtforschung (ZIS) der Universität Hamburg; 2014.

Mravčík V , Skařupová K , Orlíková B , Zábranský T , Karachaliou K , Schulte B. Use of gelatine capsules for application of methamphetamine: a new harm reduction approach. Int J Drug Policy. 2011;22(2):172–173.

Luikinga SJ , Kim JH , Perry CJ. Developmental perspectives on methamphetamine abuse: exploring adolescent vulnerabilities on brain and behavior. Prog Neuropsychopharmacol Biol Psychiatry. 2018;87(Pt A):78–84.

Reiter AM , Deserno L , Wilbertz T , Heinze HJ , Schlagenhauf F. Risk factors for addiction and their association with model-based behavioral control. Front Behav Neurosci. 2016;10:26.

Pfeiffer-Gerschel T , Schneider F , Dammer E , Braun B , Kraus L. Methamphetaminkonsum in Deutschland: Verbreitung und Problemlage. Sucht. 2019;65(4):241–249.

Springer AE , Peters RJ , Shegog R , White DL , Kelder SH. Methamphetamine use and sexual risk behaviors in US High school students: findings from a national risk behavior survey. Prev Sci. 2007;8(2):103–113.

Johnston LD , Miech RA , O'Malley PM , Bachman JG , Schulenberg JE , Patrick ME. Monitoring the Future National Survey Results on Drug Use 1975-2018: Overview, Key Findings on Adolescent Drug Use. Ann Arbor, MI: Institute for Social Research, University of Michigan; 2019.

Wittchen H-U , Behrendt S , Höfler M , . What are the high risk periods for incident substance use and transitions to abuse and dependence? Implications for early intervention and prevention. Int J Methods Psychiatr Res. 2008;17(S1):S16–S29.

Chesney E , Goodwin GM , Fazel S. Risks of all-cause and suicide mortality in mental disorders: a meta-review. World Psychiatry. 2014;13(2):153–160.

Cohen JB , Dickow A , Horner K , . Abuse and violence history of men and women in treatment for methamphetamine dependence. Am J Addict. 2003;12(5):377–385.

Pluddemann A , Flisher AJ , McKetin R , Parry C , Lombard C. Methamphetamine use, aggressive behavior and other mental health issues among high-school students in Cape Town, South Africa. Drug Alcohol Depend. 2010;109(1–3):14–19.

Sexton RL , Carlson RG , Leukefeld CG , Booth BM. Methamphetamine use and adverse consequences in the rural southern United States: an ethnographic overview. J Psychoact Drugs. 2006;38(sup3):393–404.

Darke S , Kaye S , McKetin R , Duflou J. Major physical and psychological harms of methamphetamine use. Drug Alcohol Rev. 2008;27(3):253–262.

Sommers I , Baskin D , Baskin-Sommers A. Methamphetamine use among young adults: health and social consequences. Addict Behav. 2006;31(8):1469–1476.

Smith LM , Paz MS , LaGasse LL , . Maternal depression and prenatal exposure to methamphetamine: neurodevelopmental findings from the infant development, environment, and lifestyle (ideal) study. Depress Anxiety. 2012;29(6):515–522.

Nicosia N , Liccardo Pacula R , Kilmer B , Lundberg R , Chiesa J. The economic cost of methamphetamine use in the United States, 2005. https://www.rand.org/content/dam/rand/pubs/monographs/2009/RAND_MG829.pdf. Published 2005.

Tait RJ , Whetton S , Shanahan M , . Quantifying the societal cost of methamphetamine use to Australia. Int J Drug Policy. 2018;62:30–36.

Chen CK , Lin SK , Sham PC , . Pre-morbid characteristics and co-morbidity of methamphetamine users with and without psychosis. Psychol Med. 2003;33(8):1407–1414.

Koob GF , Volkow ND. Neurobiology of addiction: a neurocircuitry analysis. Lancet Psychiatry. 2016;3(8):760–773.

Volkow ND , Boyle M. Neuroscience of addiction: relevance to prevention and treatment. Am J Psychiatry. 2018;175(8):729–740.

Verdejo-Garcia A , Lawrence AJ , Clark L. Impulsivity as a vulnerability marker for substance-use disorders: review of findings from high-risk research, problem gamblers and genetic association studies. Neurosci Biobehav Rev. 2008;32(4):777–810.

Cox WM , Klinger E. Motivational structure. Relationships with substance use and processes of change. Addict Behav. 2002;27(6):925–940.

Simons J , Correia CJ , Carey KB. A comparison of motives for marijuana and alcohol use among experienced users. Addict Behav. 2000;25(1):153–160.

Hartwell KJ , Johnson RH , McRae-Clark AL , . Motives for using: a comparison of prescription opioid, marijuana and cocaine dependent individuals. Am J Addict. 2012;21(4):390–391.

Thurn D , Kuntsche E , Weber JA , Wolstein J. Development and validation of the amphetamine-type stimulants motive questionnaire in a clinical population. Front Psychiatry. 2017;8:183–183.

Milin S , Kleinau C , Ludorf T , . Motives for illicit stimulant use a comparison of amphetamine and methamphetamine users. Suchttherapie. 2016;17(1):17–21.

Gouzoulis-Mayfrank E , Daumann J. Neurotoxicity of drugs of abuse–the case of methylenedioxyamphetamines (MDMA, ecstasy), and amphetamines. Dialogues Clin Neurosci. 2009;11(3):305–317.

McKetin R , Dawe S , Burns RA , . The profile of psychiatric symptoms exacerbated by methamphetamine use. Drug Alcohol Depend. 2016;161:104–109.

McGregor C , Srisurapanont M , Jittiwutikarn J , Laobhripatr S , Wongtan T , White JM. The nature, time course and severity of methamphetamine withdrawal. Addiction. 2005;100(9):1320–1329.

Nakama H , Chang L , Cloak C , Jiang C , Alicata D , Haning W. Association between psychiatric symptoms and craving in methamphetamine users. Am J Addict. 2008;17(5):441–446.

Warden D , Sanchez K , Greer T , . Demographic and clinical characteristics of current comorbid psychiatric disorders in a randomized clinical trial for adults with stimulant use disorders. Psychiatry Res. 2016;246:136–141.

Angelo FN , McDonell MG , Lewin MR , . Predictors of stimulant abuse treatment outcomes in severely mentally ill outpatients. Drug Alcohol Depend. 2013;131(1–2):162–165.

Brecht ML , Herbeck D. Time to relapse following treatment for methamphetamine use: a long-term perspective on patterns and predictors. Drug Alcohol Depend. 2014;139:18–25.

Salo R , Flower K , Kielstein A , Leamon MH , Nordahl TE , Galloway GP. Psychiatric comorbidity in methamphetamine dependence. Psychiatry Res. 2011;186(2–3):356–361.

Weich L , Pienaar W. Occurrence of comorbid substance use disorders among acute psychiatric inpatients at Stikland Hospital in the Western Cape, South Africa. Afr J Psychiatry (Johannesbg). 2009;12(3):213–217.

Moher D , Liberati A , Tetzlaff J , Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.

Yen CF , Chong MY. Comorbid psychiatric disorders, sex, and methamphetamine use in adolescents: a case-control study. Compr Psychiatry. 2006;47(3):215–220.

McKetin R , Ross J , Kelly E , . Characteristics and harms associated with injecting versus smoking methamphetamine among methamphetamine treatment entrants. Drug Alcohol Rev. 2008;27(3):277–285.

Farnia V , Bagher Mousavi S , Tatari F , . Prevalence of childhood attention-deficit/hyperactivity disorder (ADHD) in methamphetamine dependence: a descriptive study. Iran J Psychiatry Behav Sci. 2018;12(4):e61329.

Matsumoto T , Kamijo A , Yamaguchi A , Iseki E , Hirayasu Y. Childhood histories of attention-deficit hyperactivity disorders in Japanese methamphetamine and inhalant abusers: preliminary report. Psychiatry Clin Neurosci. 2005;59(1):102–105.

Matsumoto T , Yamaguchi A , Asami T , . Drug preferences in illicit drug abusers with a childhood tendency of attention deficit/hyperactivity disorder: a study using the Wender Utah Rating Scale in a Japanese prison. Psychiatry Clin Neurosci. 2005;59(3):311–318.

Zhang Y , Sun Y , Yu Z , . Risk factors and an early prediction model for persistent methamphetamine-related psychiatric symptoms. Addict Biol. 2020;25(1):e12709.

Luderer M , Kiefer F , Reif A , Moggi FA. ADHD in adult patients with substance use disorders. Nervenarzt. 2019;90(9):926–931.

Crunelle CL , van den Brink W , Moggi F , . International consensus statement on screening, diagnosis and treatment of substance use disorder patients with comorbid attention deficit/hyperactivity disorder. Eur Addict Res. 2018;24(1):43–51.

King G , Alicata D , Cloak C , Chang L. Psychiatric symptoms and HPA axis function in adolescent methamphetamine users. J Neuroimmune Pharmacol. 2010;5(4):582–591.

Auerbach RP , Mortier P , Bruffaerts R , . WHO world mental health surveys international college student project: prevalence and distribution of mental disorders. J Abnorm Psychol. 2018;127(7):623–638.

Hall W , Hando J , Darke S , Ross J. Psychological morbidity and route of administration among amphetamine users in Sydney, Australia. Addiction. 1996;91(1):81–87.

Zweben JE , Cohen JB , Christian D , . Psychiatric symptoms in methamphetamine users. Am J Addict. 2004;13(2):181–190.

Wada K , Fukui S. [Relationship between years of methamphetamine use and symptoms of methamphetamine psychosis. Arukoru Kenkyuto Yakubutsu Ison. 1990;25(3):143–158.

Topp L , Mattick RP. Validation of the amphetamine dependence syndrome and the SAmDQ. Addiction. 1997;92(2):151–162.

Anglin MD , Burke C , Perrochet B , Stamper E , Dawud-Noursi S. History of the methamphetamine problem. J Psychoactive Drugs. 2000;32(2):137–141.

Wang DS , Zhou CL , Chang YK. Acute exercise ameliorates craving and inhibitory deficits in methamphetamine: an ERP study. Physiol Behav. 2015;147:38–46.

Sattah MV , Supawitkul S , Dondero TJ , . Prevalence of and risk factors for methamphetamine use in northern Thai youth: results of an audio-computer-assisted self-interviewing survey with urine testing. Addiction. 2002;97(7):801–808.

Rawson RA , Gonzales R , Obert JL , McCann MJ , Brethen P. Methamphetamine use among treatment-seeking adolescents in Southern California: participant characteristics and treatment response. J Subst Abuse Treat. 2005;29(2):67–74.

Yen CF , Su YC. The associations of early-onset methamphetamine use with psychiatric morbidity among Taiwanese adolescents. Subst Use Misuse. 2006;41(1):35–44.

Semple SJ , Zians J , Strathdee SA , Patterson TL. Psychosocial and behavioral correlates of depressed mood among female methamphetamine users. J Psychoact Drugs. 2007;39(sup4):353–366.

Lin S-K , Ball D , Hsiao C-C , Chiang Y-L , Ree S-C , Chen C-K. Psychiatric comorbidity and gender differences of persons incarcerated for methamphetamine abuse in Taiwan. Psychiatry Clin Neurosci. 2004;58(2):206–212.

Harkness KL , Stewart JG , Wynne-Edwards KE. Cortisol reactivity to social stress in adolescents: role of depression severity and child maltreatment. Psychoneuroendocrinology. 2011;36(2):173–181.

Degenhardt L , Coffey C , Carlin JB , Moran P , Patton GC. Who are the new amphetamine users? A 10-year prospective study of young Australians. Addiction. 2007;102(8):1269–1279.

Briere FN , Fallu JS , Janosz M , Pagani LS. Prospective associations between meth/amphetamine (speed) and MDMA (ecstasy) use and depressive symptoms in secondary school students. J Epidemiol Community Health. 2012;66(11):990–994.

Jernigan TL , Gamst AC , Archibald SL , . Effects of methamphetamine dependence and HIV infection on cerebral morphology. Am J Psychiatry. 2005;162(8):1461–1472.

Whittle S , Lichter R , Dennison M , . Structural brain development and depression onset during adolescence: a prospective longitudinal study. Am J Psychiatry. 2014;171(5):564–571.

Zorick T , Nestor L , Miotto K , . Withdrawal symptoms in abstinent methamphetamine-dependent subjects. Addiction. 2010;105(10):1809–1818.

Takamatsu Y , Yamamoto H , Ogai Y , Hagino Y , Markou A , Ikeda K. Fluoxetine as a potential pharmacotherapy for methamphetamine dependence: studies in mice. Ann N Y Acad Sci. 2006;1074(1):295–302.

Rothman RB , Partilla JS , Dersch CM , Carroll FI , Rice KC , Baumann MH. Methamphetamine dependence: medication development efforts based on the dual deficit model of stimulant addiction. Ann N Y Acad Sci. 2000;914(1):71–81.

Rahmani S , Ahmadi S , Hassanian-Moghaddam H. Serotonin syndrome following single ingestion of high dose methamphetamine. Clin Toxicol. 2011;1(3):1000111.

Shoptaw S , Huber A , Peck J , . Randomized, placebo-controlled trial of sertraline and contingency management for the treatment of methamphetamine dependence. Drug Alcohol Depend. 2006;85(1):12–18.

Braunwarth W-D , Christ M , Dirks H , . S3 practice guideline methamphetamine-related disorders. https://www.aezq.de/mdb/edocs/pdf/literatur/s3-gl-methamphetamine-related-disorders-long.pdf. Published 2016.

Rawson RA , Chudzynski J , Gonzales R , . The impact of exercise on depression and anxiety symptoms among abstinent methamphetamine-dependent individuals in a residential treatment setting. J Subst Abuse Treat. 2015;57:36–40.

Rawson RA , Chudzynski J , Mooney L , . Impact of an exercise intervention on methamphetamine use outcomes post-residential treatment care. Drug Alcohol Depend. 2015;156:21–28.

Nock NL , Minnes S , Alberts JL. Neurobiology of substance use in adolescents and potential therapeutic effects of exercise for prevention and treatment of substance use disorders. Birth Defects Res. 2017;109(20):1711–1729.

Pisetsky EM , Chao YM , Dierker LC , May AM , Striegel-Moore RH. Disordered eating and substance use in high-school students: results from the Youth Risk Behavior Surveillance System. Int J Eat Disord. 2008;41(5):464–470.

Glasner-Edwards S , Mooney LJ , Marinelli-Casey P , . Bulimia nervosa among methamphetamine dependent adults: association with outcomes three years after treatment. Eat Disord. 2011;19(3):259–269.

Bruening AB , Perez M , Ohrt TK. Exploring weight control as motivation for illicit stimulant use. Eat Behav. 2018;30:72–75.

Dawe S , Loxton NJ. The role of impulsivity in the development of substance use and eating disorders. Neurosci Biobehav Rev. 2004;28(3):343–351.

Gordon A. Chapter 9. Eating disorders and substance use. In: Department of Health, ed. Adelaide, Australia: Australian Government; 2008.

Uhlmann S , DeBeck K , Simo A , Kerr T , Montaner JSG , Wood E. Health and social harms associated with crystal methamphetamine use among street-involved youth in a Canadian setting. Am J Addict. 2014;23(4):393–398.

Hawke JM , Jainchill N , Leon GD. Adolescent amphetamine users in treatment: client profiles and treatment outcomes. J Psychoactive Drugs. 2000;32(1):95–105.

Basedow LA , Kuitunen-Paul S , Roessner V , Golub Y. Traumatic events and substance use disorders in adolescents. Front Psychiatry. 2020;11:559.

Lopez-Patton M , Kumar M , Jones D , Fonseca M , Kumar AM , Nemeroff CB. Childhood trauma and METH abuse among men who have sex with men: implications for intervention. J Psychiatr Res. 2016;72:1–5.

Maxwell JC. A new survey of methamphetamine users in treatment: who they are, why they like “meth,” and why they need additional services. Subst Use Misuse. 2014;49(6):639–644.

Argento E , Strathdee SA , Goldenberg S , Braschel M , Montaner J , Shannon K. Violence, trauma and living with HIV: longitudinal predictors of initiating crystal methamphetamine injection among sex workers. Drug Alcohol Depend. 2017;175:198–204.

Svingen L , Dykstra RE , Simpson JL , . Associations between family history of substance use, childhood trauma, and age of first drug use in persons with methamphetamine dependence. J Addict Med. 2016;10(4):269–273.

Smith RC , Blumenthal H , Badour C , Feldner MT. An investigation of relations between crystal methamphetamine use and posttraumatic stress disorder. Addict Behav. 2010;35(6):625–627.

Schäfer I , Lotzin A , Milin S. Ungedeckte psychotherapeutische Bedarfe bei Stimulanzienkonsumenten. Psychotherapeut. 2014;59(4):300–305.

Hsieh JH , Stein DJ , Howells FM. The neurobiology of methamphetamine induced psychosis. Front Hum Neurosci. 2014;8:537–537.

Hall W , Hando J. Route of administration and adverse effects of amphetamine use among young adults in Sydney, Australia. Drug Alcohol Rev. 1994;13(3):277–284.

Grant KM , Kelley SS , Agrawal S , Meza JL , Meyer JR , Romberger DJ. Methamphetamine use in rural Midwesterners. Am J Addict. 2007;16(2):79–84.

Leamon MH , Flower K , Salo RE , Nordahl TE , Kranzler HR , Galloway GP. Methamphetamine and paranoia: the methamphetamine experience questionnaire. Am J Addict. 2010;19(2):155–168.

Harris DS , Boxenbaum H , Everhart ET , Sequeira G , Mendelson JE , Jones RT. The bioavailability of intranasal and smoked methamphetamine. Clin Pharmacol Ther. 2003;74(5):475–486.

Newton TF , Kalechstein AD , Duran S , Vansluis N , Ling W. Methamphetamine abstinence syndrome: preliminary findings. Am J Addict. 2004;13(3):248–255.

Lago JA , Kosten TR. Stimulant withdrawal. Addiction. 1994;89(11):1477–1481.

McKetin R , McLaren J , Lubman DI , Hides L. The prevalence of psychotic symptoms among methamphetamine users. Addiction. 2006;101(10):1473–1478.

Lecomte T , Dumais A , Dugre JR , Potvin S. The prevalence of substance-induced psychotic disorder in methamphetamine misusers: a meta-analysis. Psychiatry Res. 2018;268:189–192.

Lappin JM , Sara GE. Psychostimulant use and the brain. Addiction. 2019;114(11):2065–2077.

Cederlöf M , Kuja-Halkola R , Larsson H , . A longitudinal study of adolescent psychotic experiences and later development of substance use disorder and suicidal behavior. Schizophr Res. 2017;181:13–16.

Dhossche D , Ferdinand R , Van Der Ende J , Hofstra MB , Verhulst F. Diagnostic outcome of self-reported hallucinations in a community sample of adolescents. Psychol Med. 2002;32(4):619–627.

Starzer MSK , Nordentoft M , Hjorthøj C. Rates and predictors of conversion to schizophrenia or bipolar disorder following substance-induced psychosis. Am J Psychiatry. 2018;175(4):343–350.

Wodarz N , Krampe-Scheidler A , Christ M , . Evidence-based guidelines for the pharmacological management of acute methamphetamine-related disorders and toxicity. Pharmacopsychiatry. 2017;50(3):87–95.

Fonagy P , Speranza M , Luyten P , Kaess M , Hessels C , Bohus M. ESCAP expert article: borderline personality disorder in adolescence: an expert research review with implications for clinical practice. Eur Child Adolesc Psychiatry. 2015;24(11):1307–1320.

Cohen P , Chen H , Crawford TN , Brook JS , Gordon K. Personality disorders in early adolescence and the development of later substance use disorders in the general population. Drug Alcohol Depend. 2007;88(Suppl 1):S71–S84.

Trull TJ , Freeman LK , Vebares TJ , Choate AM , Helle AC , Wycoff AM. Borderline personality disorder and substance use disorders: an updated review. Bord Personal Disord Emot Dysregul. 2018;5(1):15.

Trull TJ , Jahng S , Tomko RL , Wood PK , Sher KJ. Revised Nesarc personality disorder diagnoses: gender, prevalence, and comorbidity with substance dependence disorders. J Pers Disord. 2010;24(4):412–426.

Scalzo F , Hulbert CA , Betts JK , Cotton SM , Chanen AM. Predictors of substance use in youth with borderline personality disorder. Personal Disord. 2018;9(4):390–396.

Zhang C , Luo T , Liu L , Dong H , Hao W. Prevalence rates of personality disorder and its association with methamphetamine dependence in compulsory treatment facilities in China. Front Psychiatry. 2018;9:698.

Eslami-Shahrbabaki M , Fekrat A , Mazhari S. A study of the prevalence of psychiatric disorders in patients with methamphetamine-induced psychosis. Addict Health. 2015;7(1–2):37–46.

Fenton MC , Keyes K , Geier T , . Psychiatric comorbidity and the persistence of drug use disorders in the United States. Addiction. 2012;107(3):599–609.

Kienast T , Roediger E , Kensche M , Foerster J , Daig I , Heinz A. Evidence-based psychotherapy: addiction and personality disorders as comorbidities. Nervenarzt. 2009;80(9):1050–1059.

Rizvi SL , Linehan MM. Dialectical behavior therapy for personality disorders. Curr Psychiatry Rep. 2001;3(1):64–69.

Dimeff LA , Linehan MM. Dialectical behavior therapy for substance abusers. Addict Sci Clin Pract. 2008;4(2):39–47.

Embry D , Hankins M , Biglan A , Boles S. Behavioral and social correlates of methamphetamine use in a population-based sample of early and later adolescents. Addict Behav. 2009;34(4):343–351.

Fletcher JB , Swendeman D , Reback CJ. Mental health and substance use disorder comorbidity among methamphetamine-using men who have sex with men. J Psychoactive Drugs. 2018;50(3):206–213.

Saban A , Flisher A , Laubscher R , London L , Morojele N. The association between psychopathology and substance use: adolescent and young adult substance users in inpatient treatment in Cape Town, South Africa. Pan Afr Med J. 2014;17 (Suppl 1(Suppl 1):8–8.

Rungnirundorn T , Verachai V , Gelernter J , Malison RT , Kalayasiri R. Sex differences in methamphetamine use and dependence in a Thai treatment center. J Addict Med. 2017;11(1):19–27.

Fletcher JB , Reback CJ. Antisocial personality disorder predicts methamphetamine treatment outcomes in homeless, substance-dependent men who have sex with men. J Subst Abuse Treat. 2013;45(3):266–272.

Fazel S , Danesh J. Serious mental disorder in 23000 prisoners: a systematic review of 62 surveys. Lancet. 2002;359(9306):545–550.

Kramer TL , Han X , Leukefeld C , Booth BM , Edlund C. Childhood conduct problems and other early risk factors in rural adult stimulant users. J Rural Health. 2009;25(1):50–57.

Office of the Surgeon General (US), National Center for Injury Prevention and Control (US), National Institute of Mental Health (US) and Center for Mental Health Services (US). Chapter 5 – prevention and intervention. Youth Violence: A Report of the Surgeon General. Rockville, MD: Office of the Surgeon General (US); 2001.

Dhein S , Schmelmer K , Guenther J , Salameh A. Aspects of methamphetamine abuse in adolescents and young adults in a Thuringian County. Eur Addict Res. 2018;24(2):98–105.

Barrett SP , Darredeau C , Pihl RO. Patterns of simultaneous polysubstance use in drug using university students. Hum Psychopharmacol Clin Exp. 2006;21(4):255–263.

McKetin R , Lubman DI , Lee NM , Ross JE , Slade TN. Major depression among methamphetamine users entering drug treatment programs. Med J Aust. 2011;195(3):S51–S55.

Fergusson DM , Boden JM , Horwood LJ. Cannabis use and other illicit drug use: testing the cannabis gateway hypothesis. Addiction. 2006;101(4):556–569.

Cuzen NL , Koopowitz SM , Ferrett HL , Stein DJ , Yurgelun-Todd D. Methamphetamine and cannabis abuse in adolescence: a quasi-experimental study on specific and long-term neurocognitive effects. BMJ Open. 2015;5(1):e005833–e005833.

Mendelson J , Jones RT , Upton R , Jacob P. 3rd. Methamphetamine and ethanol interactions in humans. Clin Pharmacol Ther. 1995;57(5):559–568.

Albertson TE , Derlet RW , Van Hoozen BE. Methamphetamine and the expanding complications of amphetamines. West J Med. 1999;170(4):214–219.

Mitra G , Wood E , Nguyen P , Kerr T , DeBeck K. Drug use patterns predict risk of non-fatal overdose among street-involved youth in a Canadian setting. Drug Alcohol Depend. 2015;153:135–139.

Spear LP. Consequences of adolescent use of alcohol and other drugs: studies using rodent models. Neurosci Biobehav Rev. 2016;70:228–243.

Chomchai C , Chomchai S. Global patterns of methamphetamine use. Curr Opin Psychiatry. 2015;28(4):269–274.

Basedow LA , Kuitunen-Paul S , Roessner V , Golub Y. Trauma und PTBS in jugendlichen Patienten mit einer Substanzkonsumstörung. Suchttherapie. 2019;20(S 01):P12.

Girelli G. The death penalty for drug offences: global overview 2018. In: Harm Reduction International, ed. London, UK: Harm Reduction International; 2019.

Mackey S , Allgaier N , Chaarani B , . Mega-analysis of gray matter volume in substance dependence: general and substance-specific regional effects. Am J Psychiatry. 2019;176(2):119–128.

Yoshimura T , Usui H , Takahashi N , . Association analysis of the GDNF gene with methamphetamine use disorder in a Japanese population. Prog Neuropsychopharmacol Biol Psychiatry. 2011;35(5):1268–1272.

Kotyuk E , Nemeth N , Ronai Z , Demetrovics Z , Sasvari-Szekely M , Szekely A. Association between smoking behaviour and genetic variants of glial cell line-derived neurotrophic factor. J Genet. 2016;95(4):811–818.

Chen CK , Lin SK , Sham PC , Ball D , Loh EW , Murray RM. Morbid risk for psychiatric disorder among the relatives of methamphetamine users with and without psychosis. Am J Med Genet. 2005;136b(1):87–91.

Breen MS , Uhlmann A , Ozcan S , . Parallel changes in serum proteins and diffusion tensor imaging in methamphetamine-associated psychosis. Sci Rep. 2017;7:43777.

Grant KM , LeVan TD , Wells SM , . Methamphetamine-associated psychosis. J Neuroimmune Pharmacol. 2012;7(1):113–139.

Bramness JG , Rognli EB. Psychosis induced by amphetamines. Curr Opin Psychiatry. 2016;29(4):236–241.

Crouse JJ , Lee RSC , White D , Moustafa AA , Hickie IB , Hermens DF. Distress and sleep quality in young amphetamine-type stimulant users with an affective or psychotic illness. Psychiatry Res. 2018;262:254–261.

Chang L , Alicata D , Ernst T , Volkow N. Structural and metabolic brain changes in the striatum associated with methamphetamine abuse. Addiction. 2007;102(s1):16–32.

Vuletic D , Dupont P , Robertson F , Warwick J , Zeevaart JR , Stein DJ. Methamphetamine dependence with and without psychotic symptoms: a multi-modal brain imaging study. Neuroimage Clin. 2018;20:1157–1162.

Thirthalli J , Benegal V. Psychosis among substance users. Curr Opin Psychiatry. 2006;19(3):239–245.

Egan MF , Weinberger DR. Neurobiology of schizophrenia. Curr Opin Neurobiol. 1997;7(5):701–707.

Markou A , Kenny PJ. Neuroadaptations to chronic exposure to drugs of abuse: relevance to depressive symptomatology seen across psychiatric diagnostic categories. Neurotox Res. 2002;4(4):297–313.

Bananej A , Volkl-Kernstock S , Lesch O , Walter H , Skala K. No evidence of subgroups found in amphetamine consumers in Iran. Neuropsychiatr. 2018;32(2):69–74.

Al-Tayyib A , Koester S , Langegger S , Raville L. Heroin and methamphetamine injection: an emerging drug use pattern. Subst Use Misuse. 2017;52(8):1051–1058.

Furr CDM , Delva J , Anthony JC. The suspected association between methamphetamine ('ice') smoking and frequent episodes of alcohol intoxication: data from the 1993 National Household Survey on Drug Abuse. Drug Alcohol Depend. 2000;59(1):89–93.

Bujarski S , Roche DJ , Lunny K , . The relationship between methamphetamine and alcohol use in a community sample of methamphetamine users. Drug Alcohol Depend. 2014;142:127–132.

Drake RE , Mueser KT. Psychosocial approaches to dual diagnosis. Schizophr Bull. 2000;26(1):105–118.

Jaffe C , Bush KR , Straits-Troster K , . A comparison of methamphetamine-dependent inpatients childhood attention deficit hyperactivity disorder symptomatology. J Addict Dis. 2005;24(3):133–152.

Glasner-Edwards S , Mooney LJ , Marinelli-Casey P , . Anxiety disorders among methamphetamine dependent adults: association with post-treatment functioning. Am J Addict. 2010;19(5):385–390.

Verheul R , Kranzler HR , Poling J , Tennen H , Ball S , Rounsaville BJ. Axis I and Axis II disorders in alcoholics and drug addicts: fact or artifact? J Stud Alcohol. 2000;61(1):101–110.

Kobayashi O , Matsumoto T , Otsuki M , . Profiles associated with treatment retention in Japanese patients with methamphetamine use disorder: preliminary survey. Psychiatry Clin Neurosci. 2008;62(5):526–532.

Glasner-Edwards S , Mooney LJ , Ang A , Hillhouse M , Rawson R. Does Posttraumatic Stress Disorder (PTSD) affect post-treatment methamphetamine use? J Dual Diagn. 2013;9(2):123–128.

Gilder DA , Gizer IR , Lau P , Ehlers CL. Stimulant dependence and stimulant-associated psychosis: clinical characteristics and age of onset in a Native American community sample. J Addict Med. 2014;8(4):241–248.

Niemi-Pynttäri J , Sund R , Putkonen H , Vorma H , Wahlbeck K , Pirkola S. Substance-induced psychoses converting into schizophrenia: a register-based study of 18,478 Finnish inpatient cases. J Clin Psychiatry. 2013;74(1):e94–e99.

Hellem TL , Sung YH , Shi XF , . Creatine as a novel treatment for depression in females using methamphetamine: a pilot study. J Dual Diagn. 2015;11(3–4):189–202.

Rawson RA , Shoptaw SJ , Obert JL , . An intensive outpatient approach for cocaine abuse treatment: the matrix model. J Subst Abuse Treat. 1995;12(2):117–127.

Obert JL , McCann MJ , Martinez J. The Matrix Model for Teens and Young Adults. Therapist's Manual. 2nd ed., revised and expanded update to meet DSM-5 classifications ed. Center City, MN: Hazelden; 2017.

Argento E , Strathdee SA , Tupper K , Braschel M , Wood E , Shannon K. Does psychedelic drug use reduce risk of suicidality? Evidence from a longitudinal community-based cohort of marginalised women in a Canadian setting. BMJ Open. 2017;7(9):e016025

Voss C , Ollmann TM , Miché M , . Prevalence, onset, and course of suicidal behavior among adolescents and young adults in Germany. JAMA Netw Open. 2019;2(10):e1914386.

Canadian Paediatric Society. Position statement. Age limits and adolescents. Paediatr Child Health. 2003;8(9):577–578.

van Loo HM , Romeijn J-W. Psychiatric comorbidity: fact or artifact? Theor Med Bioeth. 2015;36(1):41–60.

Courtney KE , Ray LA. Methamphetamine: an update on epidemiology, pharmacology, clinical phenomenology, and treatment literature. Drug Alcohol Depend. 2014;143:11–21.

Robins LN , Cottler LB , Bucholz KK , Compton WM , North CS , Rourke KM. Diagnostic Interview Schedule for DSM IV. St. Louis, MI: Washington University in St. Louis; 2002.

Berman AH , Bergman H , Palmstierna T , Schlyter F. Evaluation of the Drug Use Disorders Identification Test (DUDIT) in criminal justice and detoxification settings and in a Swedish population sample. Eur Addict Res. 2005;11(1):22–31.

Goldberg DP , Williams P. A Users’ Guide to the General Health Questionnaire. London, UK: GL Assessment; 1988.

Orvaschel H. Schizophrenia and Affective Disorders Schedule for Children—Epidemiological Version (KSADS-E). Unpublished manuscript. Nova University; 1995.

Derogatis LR , Lipman RS , Covi L. SCL-90: an outpatient psychiatric rating scale–preliminary report. Psychopharmacol Bull. 1973;9(1):13–28.

Steinberg AM , Brymer MJ , Kim S , . Psychometric properties of the UCLA PTSD reaction index: part I. J Trauma Stress. 2013;26(1):1–9.

Ibanez GE , Purcell DW , Stall R , Parsons JT , Gomez CA. Sexual risk, substance use, and psychological distress in HIV-positive gay and bisexual men who also inject drugs. Aids. 2005;19(Suppl 1):S49–S55.